Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Paige from Solon, OH Dyanet from Aventura, FL On Trust Very peaceful and wonderful experience
B.D EliaC
Our study revealed a significant upregulation of the GSH metabolic pathway in chemotherapy-resistant patients
Despite the possibility that additional mechanisms are also at play, the regulation of catalase expression seems to be primarily controlled at the transcriptional level
Metabolic vulnerabilities are being exploited through combinations such as sirolimus (an mTOR inhibitor) and auranofin (a thioredoxin reductase inhibitor) in advanced NSCLC and SCLC (NCT01737502)
US$ 25.42
US$ 28.15
US$ 28.14
US$ 28.63
US$ 25.06
US$ 24.61
US$ 22.18
US$ 28.38
US$ 25.43
US$ 21.27
US$ 23.69
US$ 21.82
US$ 20.25
